Anti-HIPK3/ DYRK6/ FIST3 monoclonal antibody

Anti-HIPK3/ DYRK6/ FIST3 antibody for FACS & in-vivo assay

Target products collectionGo to HIPK3/HIPK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0580-Ab-1/ GM-Tg-hg-MP0580-Ab-2Anti-Human HIPK3 monoclonal antibodyHuman
GM-Tg-rg-MP0580-Ab-1/ GM-Tg-rg-MP0580-Ab-2Anti-Rat HIPK3 monoclonal antibodyRat
GM-Tg-mg-MP0580-Ab-1/ GM-Tg-mg-MP0580-Ab-2Anti-Mouse HIPK3 monoclonal antibodyMouse
GM-Tg-cynog-MP0580-Ab-1/ GM-Tg-cynog-MP0580-Ab-2Anti-Cynomolgus/ Rhesus macaque HIPK3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0580-Ab-1/ GM-Tg-felg-MP0580-Ab-2Anti-Feline HIPK3 monoclonal antibodyFeline
GM-Tg-cang-MP0580-Ab-1/ GM-Tg-cang-MP0580-Ab-2Anti-Canine HIPK3 monoclonal antibodyCanine
GM-Tg-bovg-MP0580-Ab-1/ GM-Tg-bovg-MP0580-Ab-2Anti-Bovine HIPK3 monoclonal antibodyBovine
GM-Tg-equg-MP0580-Ab-1/ GM-Tg-equg-MP0580-Ab-2Anti-Equine HIPK3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0580-Ab-1/ GM-Tg-hg-MP0580-Ab-2; GM-Tg-rg-MP0580-Ab-1/ GM-Tg-rg-MP0580-Ab-2;
GM-Tg-mg-MP0580-Ab-1/ GM-Tg-mg-MP0580-Ab-2; GM-Tg-cynog-MP0580-Ab-1/ GM-Tg-cynog-MP0580-Ab-2;
GM-Tg-felg-MP0580-Ab-1/ GM-Tg-felg-MP0580-Ab-2; GM-Tg-cang-MP0580-Ab-1/ GM-Tg-cang-MP0580-Ab-2;
GM-Tg-bovg-MP0580-Ab-1/ GM-Tg-bovg-MP0580-Ab-2; GM-Tg-equg-MP0580-Ab-1/ GM-Tg-equg-MP0580-Ab-2
Products NameAnti-HIPK3 monoclonal antibody
Formatmab
Target NameHIPK3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HIPK3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species HIPK3/ DYRK6/ FIST3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0580
    Target NameHIPK3
    Gene ID10114,15259,83617,693786,475947,101091475,538866,106781398
    Gene Symbol and SynonymsANPK,DYRK6,FIST3,HIPK3,mir-1902,PKY,YAK1
    Uniprot AccessionQ9H422,O88850
    Uniprot Entry NameHIPK3_HUMAN,HIPK3_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000110422
    Target ClassificationKinase

    The target: HIPK3, gene name: HIPK3, also named as DYRK6, FIST3, PKY, YAK1. Enables protein serine/threonine kinase activity. Involved in mRNA transcription; negative regulation of apoptotic process; and protein phosphorylation. Located in cytosol; nuclear body; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.